Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study With Biological Assessment: Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban

NCT03136510 is registered in ClinicalTrials.gov with Hopital Lariboisière as lead sponsor.

NCT NCT03136510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03136510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study With Biological Assessment: Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban
Lead sponsor
Hopital Lariboisière
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2016
Completion date
March 31, 2019
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coagulation disorder, non valvular atrial fibrillation